Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

Sponsor
Ottawa Regional Cancer Centre
Study ID
NCT00002887
Phase
PHASE1
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • cisplatin — DRUG
  • etoposide — DRUG
  • hydroxyurea — DRUG
  • vinblastine sulfate — DRUG
  • vindesine — DRUG
  • vinorelbine tartrate — DRUG
  • drug resistance inhibition treatment — PROCEDURE

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug is a way to kill more tumor cells. PURPOSE: Phase I trial to study the effects of hydroxyurea plus combination chemotherapy in patients with non-small cell lung cancer.

Key Dates

Start date
Jul 31, 1995
Status verified
Oct 2001

Study Design

Enrollment
30 participants (estimated)
Primary purpose
TREATMENT

Related Studies